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ABSTRACT 
Modern  radiotherapy  is  characterised  by  a  better  target  definition  through  medical  imaging  accompanied  by 
significantly  improved  radiation  delivery  methods,  most  notably  Intensity-Modulate  Radiation  Therapy  (IMRT). 
However, the treatment can only be as accurate as the positioning of patients for their daily radiotherapy fraction. It is in 
this  context  that  a  number  of  imaging  modalities  -  ranging  from  ultrasound  to  on-board  kilovoltage  imaging  and 
computed  tomography  (CT)  -  have  found  their  way  into  the  treatment  room  where  they  verify  accurate  patient 
positioning prior to or even during delivery of radiation. Helical tomotherapy (HT) combines IMRT delivery with in-
built image guidance using megavoltage CT scanning. This paper discusses the initial experience of different centres 
with IGRT using HT illustrated by a number of clinical examples from the installation in London in Ontario, Canada, 
one of the world’s first HT sites. We found that HT allows the delivery of highly conformal radiation dose distributions 
combined with adequate daily image acquisition. An important feature of this unit is its seamless integration, which also 
includes a customised inverse treatment planning system and a quality assurance module for individual patients. © 2007 
Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
  Clinical  experience  is  always  a  crucial 
component in the evaluation of any new technology in 
radiation  therapy  and  helical  tomotherapy  (HT)  is  no 
exception.  In  the  early  implementation  stages,  the 
attention was focused on retrospective comparisons [1-9] 
of  treatment  plans  developed  for  different  radiation 
delivery options in search of clinical scenarios where HT 
is  able  to  offer  a  significant  improvement  due  to  its 
specific  technological  design,  as  discussed  in  the 
preceding  review  [10].  These  plan  comparisons 
concluded that indeed HT can provide improved normal 
tissue  sparing  and  highly  conformal  target  coverage. 
Image-guided radiation therapy (IGRT) available on HT, 
thanks to on-board megavoltage computed tomography 
(MVCT) implemented in the commercially available Hi-
ART model, allows daily patient setup verification and 
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repositioning. In this report, the first results on its use in 
phantom studies and clinical practice are reviewed. 
CLINICAL EXAMPLES OF IMAGE GUIDANCE IN 
TOMOTHERAPY 
MVCT was found to be an important imaging tool 
for  precise  radiation  delivery  because  it  provides 
considerably  more  anatomical  detail  than  conventional 
radiation  therapy  port  films  used  for  patient  setup 
verification. There is a growing number of publications 
comparing  treatment  plans  of  different  radiotherapy 
techniques to HT delivery. The latter is predicted to have 
some advantages, especially concerning homogeneity of 
the  dose  distribution  in  the  target  [4,11-15].  In  the 
following,  we  would  like  to  illustrate  the  specific 
characteristics  of  HT  treatment  plans  using  clinical 
examples  from  our  practice  in  London,  in  Ontario, 
Canada.  Lung  cancer  was  chosen  since  the  treatment 
outcomes are quite bad and there is an indication that 
dose escalation may improve clinical outcomes [16]. In 
order to achieve this, the dose to normal lung must be 
reduced. This is a significant challenge in radiation dose 
delivery.  Head  and  neck,  and  prostate,  the  two  other 
examples chosen, are the most common applications for 
IMRT.  Radiotherapy  is  often  the  primary  treatment 
modality in these diseases and in both cases, it has been 
shown  that  normal  tissue  toxicity  can  be  reduced  by 
using advanced radiotherapy techniques. 
Lung cancer 
Planning  studies  on  the  use  of  HT  for  treating 
localised  lung  cancer  showed  more  conformal  dose 
distribution for the target and better sparing of normal 
structures [2,17,18]. It would result in a better clinical 
outcome  for  radiation  treatment  if  the  patient  setup, 
target shape, size and location remain the same as at the 
time when this patient was imaged for planning. If these 
conditions  are  not  met,  a  more  conformal  dose 
distribution  might  partially  miss  the  target  and  deliver 
high  dose  to  the  sensitive  organs.  Several  imaging 
techniques  have  demonstrated  significant  variations  of 
the  tumour  volume  during  radiotherapy  treatment: 
electronic  portal  imaging  showed  tumour  shrinkage  of 
20% or more in 40% of patients [19], repeat kilovoltage 
CT studies for 40 patients revealed a time trend towards 
decreasing  gross  tumour  volumes  (GTVs)  during 
fractionated  stereotactic  radiotherapy  [20],  and  MVCT 
on  tomotherapy  system  allowed  daily  volumetric 
evaluation  [21].  These  findings  indicate  that  periodic 
adjustments of treatment plans during a treatment course 
are needed to account for changes in shape and location 
of the target volume and critical structures when highly 
conformal  techniques  such  as  IMRT  are  used.  A  pilot 
feasibility  trial  of  10  patients  with  non-small-cell  lung 
cancer  provided  results  on  contouring  targets  on 
tomotherapy MVCT and conventional CT images [22]. 
The volumetric agreement between conventional CT and 
MVCT was excellent in 5 out of 7 patients with lesions 
located primarily in the lung parenchyma while it was 
suboptimal for primary mediastinal disease. Kupelian et 
al. [21] reported their study of tumour regression during 
external  beam  radiotherapy  for  10  patients  with  non-
small-cell  lung  cancer.  This  tumour  reduction  study 
using on-board MVCT on tomotherapy system gave full 
volumetric  evaluation,  which  was  not  possible  by 
observations made on portal images obtained during the 
course of treatment [19]. MVCT scans of the targeted 
areas  were  performed  multiple  times  during  treatment. 
The  frequency  of  scanning  was  determined  by  the 
treating physicians so that a total of 274 MVCT scans 
were obtained on the 10 patients in the range of 9 to 35 
scans  per  patient.  Tumour  volumes  were  determined 
within  the  treatment  planning  system,  and  not  by  any 
manual method. For all 10 tumours, the average decrease 
in volume was 1.2% per day with a range of 0.6% to 
2.3% per day. The lowest rate of shrinkage was observed 
for the smallest lesion with an initial volume of 5.9 cm
3. 
The highest rate was observed in the largest lesion with 
an  initial  volume  of  737  cm
3.  Other  factors  such  as 
histology,  level  of  necrosis  and  dose-per-fraction  may 
play  a  role  in  tumour  size  reduction  [23].  Direct 
evaluation  of  tumour  regression  using  MVCT 
immediately  before  treatment  indicates  a  potential 
necessity for plan updating during the treatment [24]. If 
tumour shrinkage during radiation treatment is clinically 
significant,  treatment  plan  re-optimisation  should  be 
considered,  so  that  the  dose  to  the  target  remains  as 
initially  prescribed  and  improved  sparing  of  sensitive 
structures (such as normal lung volume) can be achieved 
[2].  The  clinical  significance  of  ‘plan  updating’  (or 
adaptive radiotherapy) remains to be demonstrated and 
the  correlation  of  tumour  regression  with  clinical 
outcomes should be studied [25]. Another retrospective 
study of tumour regression during treatment on a HT unit 
of 25 patients with lung cancer showed partial response 
in  3  (12%),  marginal  response  in  5  (20%)  and  stable 
disease in 17 (68%) patients [26]. Tumour regression of 
more  than  25%  was  observed  in  10  patients  (40%). 
However, the authors questioned the clinical significance 
of  this  regression  and  field  reductions  during 
radiotherapy  because  there  was  no  way  to  document 
histological disease clearance. In our opinion, a follow-
up for a sufficiently long period of time after treatment 
may be a way of answering this question. 
There are some cases of dramatic anatomy changes 
revealed  by  MVCT  imaging  where  a  re-planning  is 
absolutely  necessary.  Figure  1  demonstrates  one  such 
example  of  a  patient  with  non-small-cell  lung  cancer 
treated on tomotherapy unit at our centre in 2005. Figure 
1a shows one axial slice of the kVCT study used for the 
initial  treatment  plan  #1.  However,  when  the  patient 
came for treatment 22 days after this study, the MVCT 
indicated (see Figure 1b) that the tumour had displaced 
both anteriorly and superiorly probably as a result of a 
collapse  of  one  of  the  lung  segments.  Another  kVCT 
study was performed (see Figure 1c), which confirmed 
the findings on MVCT and was used for creating plan #2. 
This plan was delivered for 18 fractions and daily MVCT S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e17    3 
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images showed only slight reduction of the GTV until 
the day when the atelectasis was resolved and the tumour 
moved  back  as  shown  in  Figure  1d. Then  yet  another 
kVCT  study  was  performed  as  shown  in  Figure  1e;  it 
was  used  for  plan  #3.  The  latter  was  applied  for  the 
remaining fractions and the MVCT image on the final 
day  of  treatment  is  shown  in  Figure  1f.  Clearly,  such 
dramatic changes in tumour/normal tissue anatomy can 
only be detected by daily CT imaging of the patient. 
Head & neck 
Among  the  tumour  sites,  head  and  neck  represent 
specific challenges and opportunities for high-precision 
radiotherapy planning and delivery. The proximity – in 
most cases – between the clinically manifest GTV and 
the critical organs at risk and the fact that internal motion 
of tissues and organs tends to be less of an issue in the 
head and neck region favors the use of high precision 
IMRT  [27].  Hansen  et  al.  have  found  that  repeat  CT 
imaging and re-planning during the course of IMRT for 
patients with head and neck cancer is essential because 
the clinical target volume decreased at a median rate of 
1.7%-1.8% per treatment day and the volume loss was 
frequently  asymmetric  [28].  Figure  2  illustrates  the 
importance of daily setup corrections in the case of the 
patient  shown  in  Figure  3  from  our  companion  paper 
[10].  A  dose  of  60  Gy  to  90%  of  the  planning  target 
volume  (PTV)  was  prescribed  with  priority  of  sparing 
spinal cord and trachea. This patient lost weight during 
treatment (from 133 kg at the start to 124 kg at the end of 
treatment),  resulting  in  changed  patient  anatomy 
especially in the treatment area. The vector shifts used 
for  daily  patient  setup  alignment  for  this  patient  as  a 
function of time are shown in Figure 3. 
 
Figure 2  kVCT images (left) before the treatment and (right) after delivery of 22 fractions for the patient with 
significant weight loss. 
 
 
Figure 3  The values of vector shifts introduced daily based on matching of the PTV contour used for planning 
(red line on Fig. 2a) with the daily MVCT images. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e17    4 
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Re-treatment  of  spinal  metastasis  is  extremely 
difficult  because  the  spinal  cord  typically  receives  a 
radiobiological equivalent dose of 40 to 45 Gy given in 2 
Gy fractions during the first course of treatment, so that 
the risk of radiation myelitis after a second course is high 
[29].  Mahan  et  al.  evaluated  a  feasibility  of  image-
guided  tomotherapy  for  re-treatment  of  the  vertebral 
spine  [30].  They  performed  measurements  of  dose 
gradients and maximum cord doses using a cylindrical 
phantom, tested the ability of MVCT images to localize 
spinal anatomy and used this experience for re-treatment 
of 8 patients with cord compressions to a mean dose of 
28  Gy  using  HT.  The  total  imaging  system  error  was 
measured by repeat imaging of an anthropomorphic head 
phantom. At first, kVCT images were acquired on a CT 
simulator and transferred to the tomotherapy database for 
image  fusion.  The  phantom  was  placed  in  the  correct 
position  relative  to  the  machine  isocenter,  so  that  any 
non-zero setup shifts calculated by the image guidance 
system represent error in the imaging and fusion process. 
MVCT  images  were  acquired  over  a  15  cm  range 
superior-inferior and different options of the automatic 
image fusion algorithm were used. Total imaging system 
errors (1 σ) of ±0.6 mm, ±0.5 mm, and ±0.6 mm were 
obtained by "Bone", "Bone and Soft Tissue", and "Full-
image"  options,  respectively.  The  uncertainty  in  the 
superior-inferior  direction  (±0.6  mm)  was  twice  the 
uncertainty in the anterior-posterior and lateral directions 
(±0.3 mm). 
It should be noted that the total clinical error may be 
much  larger  because  real  patients  can  move  during 
treatment  and/or  the  vertebral  column  can  align  in  a 
different  position  relative  to  the  treatment  plan.  In 
radiotherapy  of  8  patients  with  previously  treated 
vertebral  metastasis,  Mahan  et  al.  acquired  MVCT 
images  through  the  PTV,  autofused  them  with  the 
planning kVCT images, displaced the patients according 
to  the  calculated  MVCT/kVCT  shifts  and  again 
performed  MVCT  study  to  verify  that  the  shifts  were 
correctly  applied  and  to  assess  intrafraction  motion 
before  treatment  delivery.  The  range  of  the  total 
interfraction displacement with respect to the positioning 
on external laser marks was as great as 15 mm [30]. The 
standard deviation was 4.0 mm, 4.1 mm, and 4.3 mm in 
the  anterior-posterior,  lateral  and  superior-inferior 
directions, respectively. Dose gradients of 10% per mm 
were found achievable by HT in phantom measurements 
for a geometry representing the spinal cord as a 10 mm 
diameter cylinder and a 25 mm thick ‘vertebrae’. A very 
small 3 mm margin was used for expanding the GTV to 
the PTV assuming high accuracy of positioning and high 
dose gradients. As a result of such treatment 6 out of 8 
patients  had  complete  relief  of  their  pre-treatment 
symptoms,  2  had  partial  relief,  and  2  died  of  distant 
disease during the mean follow-up of 15.2 months [30]. 
Prostate 
A  group  from  Milan  reported  their  estimates  of 
systematic and random set-up errors by using on-line as 
well  as  off-line  setup  correction  protocols.  They  have 
modeled  the  average  systematic  error  and  the  residual 
error  for  the  case  of  post-operative  prostate  cancer 
(hypofractionated schedule 20 Gy in 2.9 Gy/fraction) and 
the minimum number of treatment sessions necessary to 
correctly estimate systematic set-up error [31]. Another 
study of effectiveness of daily prostate registration on a 
tomotherapy  unit  was  done  by  K.  Langen  et  al.  [32] 
using  120  alignments  from  3  patients  with  implanted 
fiducial markers. They retrospectively compared manual 
registration (i.e., visual matching of the prostate kVCT 
image used for planning and current MVCT image) by 
different  techniques.  The  reference  alignment  was 
calculated based on the fiducial markers’ centre of mass. 
If three implanted solid gold markers clearly visible both 
in kVCT and MVCT were used, the relative number of 
 
 
 
Figure 4  Image showing both kVCT (grey) and MVCT (green) 
images  taken  (top)  before  and  (bottom)  after 
registration. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e17    5 
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alignments, which differed by more than 3 mm from the 
reference, were 3%, 6% and 3% in the anterior-posterior, 
superior-inferior  and  lateral  directions,  respectively.  If 
gold markers were disregarded and registration was done 
for the prostate as seen on the MVCT with the prostate as 
seen on the planning kVCT scan, the respective values 
for  the  same  deviations  were  24%,  33%  and  3%.  No 
alignments differed more than 5 mm by this anatomy-
based technique. If the organ contours from the plan (the 
kVCT images as such were not used in this case) were 
used  for  registration  with  the  prostate  MVCT  image, 
there were more deviations from the reference case by 
more than 3 mm: the respective values were 55%, 48% 
and 21%. The anatomy-based registrations outperformed 
the contour-based registration both in terms of agreement 
with a marker-based centre-of-mass reference alignment 
and inter-user variability. 
The prostate gland can be identified with sufficient 
contrast  on  MVCT  images  as  shown  for  the  patient 
treated in our institution on images taken before and after 
registration  with  diagnostic  kVCT  study  (Figure  4). 
Daily  registration  shifts  for  this  patient  are  shown  in 
Figure  5  for  anterior/posterior,  lateral  and  superior  / 
inferior  directions.  The  couches  (‘patient  support 
assembly’) on diagnostic CT and tomotherapy unit have 
different mechanical properties, so a heavier patient with 
the  same  initial  setup  made  on  external  marks  is  in  a 
lower  position  on  the  more  flexible  couch  on 
tomotherapy.  This  is  detected,  taken  into  account  and 
corrected by MVCT imaging. 
Song  et  al.  evaluated  the  image-guidance 
capabilities of MVCT by comparing volumes of prostate 
contours  outlined  on  MVCT  and  kVCT  studies  of  the 
same 5 patients [33]. Seven observers did the contouring 
twice with an interval of 2 months, which allowed the 
evaluation  of  inter-  and  intraobserver  variability.  The 
volumes defined on the  kVCT were smaller and  more 
consistent  compared  with  the  MVCT  results  (54.1  ± 
8.6rms  cm
3  and  ,  59.9  ±  14.8rms  cm
3,  respectively).  On 
average,  the  increase  in  the  clinical  target  volume 
variability   σ  =  √(σ
2
MVCT  -  σ
2
kVCT),  for  both 
interobserver and intraobserver studies was 0.32 cm [33]. 
This outcome is not surprising, because observers tend to 
segment larger volumes on images with lower soft-tissue 
contrast [34,35]. Song et al. suggested that the techniques 
that  do  not  require  contours  for  deformable-image 
registration,  such  as  intensity-driven  dose-warping 
techniques [36,37] may be more suitable for MVCT. 
When imaging the thorax or abdomen of a patient, 
respiration-induced artefacts such as blurring, doubling, 
streaking and distortion degrade the image quality and 
affect the target localisation ability [38]. These artefacts 
depend  on  the  ratio  between  breathing  cycle  and  the 
gantry rotation speed. In conventional CT or a modern 
CT scanner, each rotation of the scan can be completed 
within  1  s  or  less,  during  which  the  organ  motion  is 
relatively  small.  A  single  slice  of  MVCT  in  HT  is 
reconstructed  from  a  180
o  rotation  in  5  s,  which  will 
introduce  motion  artefacts  from  breathing.  However, 
other  competing  techniques  suffer  from  the  same 
problem, e.g., a cone-beam CT scan takes typically 45 s 
to 1 min for acquiring the projection data in a full 360
o 
scan  [39].  Some  investigations  of  motion  artefacts  in 
tomotherapy imaging were done [40-42] and it can be 
expected that future developments will allow for faster 
image acquisition. Several groups have also worked on 
gated HT delivery [43,44]. It will be interesting to see 
how  similar  approaches  can  be  utilised  for  improved 
MVCT acquisition in the future. 
 
Figure 5  Daily shifts in different directions after registration of the patient with prostate cancer. The adjustments 
in anterior/posterior  direction have  a  systematic  shift  due  to  different  mechanical  properties  of  the 
couches in the diagnostic CT scanner and the tomotherapy unit. S Yartsev et al. Biomed Imaging Interv J 2007; 3(1):e17    6 
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CONCLUSION 
Clinical  experience  with  HT  is  rapidly  growing, 
stimulated  by  encouraging  dosimetric  results  from 
planning  studies  of  this  method  in  comparison  with 
traditional  techniques.  Preliminary  results  of 
implementation of IGRT in a tomotherapy setting shows 
that  the  on-board  MVCT  image  acquisition  system 
allows  improved  patient  positioning.  Increased  setup 
precision  permits  the  use  of  smaller  margins  around 
targets and organs at risk. Clinical experience in different 
institutions has proved the usefulness of MVCT imaging 
for corrections of patient setup leading to the possibility 
of better tumour control and a better sparing of healthy 
tissues.  IGRT  benefits  individual  patients  and  also,  by 
combining  information  from  many  patients,  allows 
radiotherapy  departments  to  develop  rational  strategies 
for  margin  design  and  the  identification  of  potential 
weaknesses in the treatment chain. 
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Figure 1  Screenshots of images of the patient with lung cancer for (a) initial kVCT image done 35 days before 
the treatment start, (b) MVCT image taken 13 days before the treatment start, (c) second MVCT image 
done 4 days before the treatment start, (d) MVCT image taken before fraction 18 on day 26 of the 
treatment, (e) third kVCT image done on day 33 of the treatment, (f) MVCT image taken on the last 
(52nd) day of the treatment, fraction 30. 